Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0NI9X
|
|||
| Former ID |
DNCL002736
|
|||
| Drug Name |
Autologous stem cell therapy
|
|||
| Indication | Spinal cord injury [ICD-11: ND51.2] | Phase 3 | [1] | |
| Ischemia [ICD-11: 8B10-8B11; ICD-9: 459.89] | Clinical trial | [2] | ||
| Company |
California Stem Cells
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fifteen Cell Therapies/Stem Cell Therapies in Phase III Clinical Trials. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.